Cynata Therapeutics Ltd. engages in the development and commercialization of therapeutic products. The firm is focused on the development of therapies based on Cymerus, which is a therapeutic stem cell platform technology. Cymerus uses induced pluripotent stem cells (iPSCs) to manufacture cell therapy products, including mesenchymal stem cells (MSCs), at commercial scale. Its product candidates include CYP-001, CYP-004 and CYP-006TK. CYP-001 is under Phase II clinical trials with a focus on treatment for steroid-resistant acute graft versus host disease (GvHD) and a Phase 1/II trial in patients undergoing kidney transplantation. CYP-006TK is a Cymerus iPSC-derived MSC topical wound dressing product candidate. This product is used in the Company’s Phase I clinical trial in diabetic foot ulcers (DFU). CYP-004, is an iPSC-derived MSC product for intra-articular injection (injection into a joint), is ongoing with a Phase III trial in patients with osteoarthritis of the knee.
Principales calificaciones de analistas para CYYNF
Basado en 5 analistas que dan calificaciones de acciones a CYYNF, actualizado el Dec 01, 2021
Buy
Strong buy
1
Buy
3
Hold
1
Sell
0
Strong sell
0
Leveraging in-depth analyst evaluations, we have synthesized key insights from expert assessments to present a positive outlook for CYYNF. Analysts highlight solid fundamentals and favorable market sentiment, suggesting upside potential in the near term. Based on this thorough expert analysis, we maintain an optimistic view of this stock. Our conclusion: CYYNF is a Buy candidate.
CYYNF stock price ended at $0.15 on lunes, after rising 25.00%
On the latest trading day Nov 17, 2025, the stock price of CYYNF rose by 25.00%, climbing from $0.15 to $0.15. Throughout the session, the stock experienced a volatility of 0.00%, with prices fluctuating between a daily low of $0.15 and a high of $0.15. Alongside this price increase, trading volume also rose by 3.0K shares, reflecting strong market interest that may signal continued bullish momentum in the near term. In total, 2.0K shares were traded, amounting to a market value of approximately $35.6M.
Señales Técnicas de CYYNF
Resumen de Señales Técnicas
Señales de compra 0
Señales Neutras 7
Señales de venta 0
Strong Sell
Sell
Neutral
Buy
Strong Buy
CYYNF actualmente presenta 0 señales de compra y 0 señales de venta. La acción ha estado en una tendencia alcista desde 12:00 AM, con un cambio total en el precio de 87.5% durante este período. En general, los indicadores técnicos apuntan a una perspectiva Neutral para el mediano plazo.
Señales alcistas/bajistas para CYYNF
Analizamos indicadores clave como medias móviles, RSI, MACD y volumen de negociación para generar señales alcistas y bajistas para CYYNF. Estas perspectivas te ayudan a tomar decisiones de inversión más informadas.
Preguntas de seguimiento
¿Cómo se aplican los indicadores de análisis técnico a CYYNF?
¿Cuáles son los niveles de retroceso de Fibonacci para CYYNF?
¿Cuál es el RSI de Cynata Therapeutics Ltd?
¿Cuál es el precio de Cynata Therapeutics Ltd para los próximos 12 meses?
¿Hasta dónde se espera que suba Cynata Therapeutics Ltd?